PHASQ — PhaseBio Pharmaceuticals Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$3.73m
- $10.83m
U.S. STOCKS ON THE MOVE-Fitbit, L Brands, Luckin Coffee, Monster Beverage, Infosys
PhaseBio Pharma: Rises after $120 mln funding deal with SFJ Pharma
NASDAQ RESUMED AT 10:00 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:50 AM
NASDAQ RESUMED AT 09:50 AM
Development Collaboration With Sfj Pharmaceuticals For Pb2452
Brief: Phasebio Pharmaceuticals Provides Update on Payments to SFJ if The FDA Approves BLA For Pb2452
NASDAQ TRADE HALT HALT NEWS PENDING AT 09:00 AM
Brief: Phasebio Pharma Files For Mixed Shelf Offering Of Up To $200 Million
U.S. STOCKS ON THE MOVE-Tesla, Amazon, Tapestry, Qiagen
Brief: Phasebio Pharmaceuticals Posts Q3 Loss Per Share $0.40
Brief: Phasebio Expands Executive Management Team
Brief: Phasebio Announces First Patient Dosed In Phase 2B Clinical Trial Of PB2452 For Reversal Of The Antiplatelet Activity Of Ticagrelor
U.S. STOCKS ON THE MOVE-Match Group, EBay, Fitbit, Philip Morris International, Nike
U.S. STOCKS ON THE MOVE-Marathon Petroleum Corp, Synnex, PhaseBio Pharmaceuticals
U.S. STOCKS ON THE MOVE-Nike, PhaseBio Pharmaceuticals, Lannett, Comtech Telecommunications
U.S. STOCKS ON THE MOVE-Synnex, Lannett, Celgene Corp, Titan Medical
U.S. STOCKS ON THE MOVE-Nike, Broadcom, Comtech Telecom,
PhaseBio jumps after completing trial for drug to reverse blood-thinner effects